Skip to main content
. 2017 May 15;56(10):1193–1198. doi: 10.2169/internalmedicine.56.6998

Figure 2.

Figure 2.

The clinical course of Case 1, including the symptoms, the treatment, and the laboratory data. Hyper-CVAD: hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen, HD-MTX/Ara-C: high-dose methotrexate and cytarabine regimen, RT: radiotherapy, PET/CT: positron emission tomography combined with computed tomography, LDH: leucine dehydrogenase